YOLFTbeta
Vivani Medical Inc.

Vivani Medical Inc.

VANI · NASDAQ · Healthcare / Biotechnology

1.01USD+0.03 (+2.70%)

Price History

Full chart

Market Stats

Previous Close0.9834
Open0.97
Day Range0.8881 – 1.03
52-Week Range0.923 – 1.92
Volume365.91K
Market Cap112.75M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.36
Dividend Yield0.00%
Beta3.28
50-Day Avg1.34
200-Day Avg1.28

About

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Adam Mendelsohn Ph.D.
  • Employees42
  • Headquarters1350 South Loop Road, Alameda, CA, United States, 94502, USA
  • Websitehttps://www.vivani.com

Leadership

  • Dr. Adam Mendelsohn Ph.D.Co-Founder, CEO & Director · b. 1982
  • Mr. Anthony Edward Baldor M.B.A.Chief Financial Officer · b. 1982
  • Mr. Truc Le M.B.A.Chief Operations Officer · b. 1953
  • Dr. Lisa E. Porter M.D.Chief Medical Officer · b. 1964
  • Mr. Donald Dwyer M.B.A.Chief Business Officer & Corporate Secretary · b. 1959

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.37M1.56M3.40M8.95M3.98M7.96M6.90M3.38M1.00K2600000
Growth (%)-+14.46%+117.12%+163.40%-55.47%+99.85%-13.41%-51.00%-99.97%-74.00%-100.00%---
Cost of Revenue4.40M5.63M3.56M4.30M9.35M7.75M4.89M2.15M167.00K345.00K381.00K357.00K400.00K424.00K
Gross Profit-3.03M-4.06M-160.28K4.65M-5.36M211.00K2.01M1.23M-167.00K-345.00K-381.00K-357.00K-400.00K-424.00K
Gross Margin-221.58%-259.72%-4.72%51.93%-134.60%2.65%29.12%36.31%-16700.00%-132692.31%----
Operating Expense12.99M13.93M21.07M24.70M27.85M28.92M36.83M31.82M9.08M12.98M20.86M26.61M24.28M27.13M
Operating Income-16.02M-18.00M-21.23M-20.05M-33.21M-28.71M-34.83M-30.60M-9.24M-13.32M-21.24M-26.96M-24.68M-27.56M
Operating Margin-1171.82%-1150.05%-624.91%-223.99%-833.38%-360.48%-505.00%-905.50%-924300.00%-5124230.77%----
EBITDA-15.69M-17.64M-27.89M-19.68M-32.75M-28.06M-34.66M-33.18M-8.89M-12.43M-19.16M-25.30M-23.09M-26.18M
EBITDA Margin-1147.39%-1127.18%-820.75%-219.92%-821.76%-352.32%-502.60%-981.89%-888900.00%-4780000.00%----
Net Income-16.28M-22.97M-35.20M-20.02M-33.18M-28.52M-35.09M-33.59M-9.28M-12.77M-13.89M-25.65M-23.49M-26.61M
Net Income Margin-1190.67%-1467.73%-1035.99%-223.66%-832.60%-358.06%-508.90%-994.14%-927900.00%-4912692.31%----
R&D3.05M3.25M5.04M3.04M5.35M7.99M10.21M16.50M6.87M11.00M14.17M16.97M15.74M18.13M
R&D as % of Total Revenue222.73%207.58%148.36%33.92%134.18%100.36%147.98%488.22%686500.00%4231538.46%----
Interest Expense267.03K5.01M7.03M29.00K--000550.00K7.35M---
Interest Expense % of Total Revenue19.53%320.37%207.02%0.32%--0.00%0.00%0.00%211538.46%----

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.99M12.67M43.07M28.25M16.81M14.50M10.68M16.60M5.22M5.45M51.13M45.80M41.56M39.39M
Total Liabilities11.04M21.89M8.45M7.98M5.66M6.62M7.60M9.32M3.27M2.99M6.82M25.04M23.95M23.66M
Total Equity-3.04M-9.22M34.62M20.27M11.15M7.88M3.08M7.28M1.95M2.46M44.31M20.76M17.61M15.73M
Cash144.75K62.56K619.41K15.96M10.88M604.00K4.47M11.33M2.08M2.18M45.08M20.65M18.35M16.23M
Total Debt8.33M19.21M-----2.60M2.47M1.81M955.00K20.70M19.31M18.86M
Net Debt8.18M19.15M-619.41K-15.96M-10.88M-604.00K-4.47M-8.72M386.00K-366.00K-44.12M42.00K961.00K2.62M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-15.32M-17.43M-17.09M-20.55M-25.07M-23.95M-29.81M-27.63M-7.62M-9.19M-18.79M-23.70M-20.79M-24.32M
Investing Cash Flow-2.85M-4.55M-25.95M17.52M4.89M2.84M-163.00K-493.00K-150.00K-14.00K-338.00K-887.00K-556.00K-1.17M
Financing Cash Flow17.98M21.97M43.80M2.76M20.45M21.17M26.60M34.99M9.19M75.62M63.39M133.00K19.05M23.27M
Capital Expenditure196.08K246.00K560.35K762.00K490.00K265.00K163.00K493.00K150.00K14.00K338.00K887.00K556.00K1.17M
Free Cash Flow-15.52M-17.67M-17.65M-21.31M-25.56M-24.21M-29.97M-28.12M-7.77M-9.20M-19.13M-24.59M-21.34M-25.49M
FCF to OCF101.28%101.41%103.28%103.71%101.95%101.11%100.55%101.78%101.97%100.15%101.80%103.74%102.67%104.82%

Earnings

Report DateMar 11, 2015May 13, 2015Aug 4, 2015Oct 29, 2015Mar 3, 2016Apr 28, 2016Jul 28, 2016Nov 2, 2016Mar 9, 2017May 3, 2017Aug 1, 2017Nov 2, 2017Mar 7, 2018May 10, 2018Aug 7, 2018Nov 7, 2018Mar 13, 2019May 15, 2019Aug 6, 2019Nov 14, 2019Mar 19, 2020Jun 26, 2020Aug 13, 2020Nov 12, 2020Mar 16, 2021Apr 29, 2021Aug 10, 2021Nov 4, 2021Mar 10, 2022May 19, 2022Aug 10, 2022Nov 14, 2022Mar 31, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 26, 2024May 13, 2024Aug 13, 2024Nov 13, 2024Mar 31, 2025May 12, 2025Aug 13, 2025Nov 13, 2025Mar 26, 2026May 13, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate---0.14-3.36-3.36-3.84-3.60-3.84-4.08-3.36-3.60--3.36--3.36-3.36-2.64-1.44-1.44-1.44-1.47-1.23-1.23-0.41-0.42-0.44-0.35-0.35-0.04--0.000.00-0.12-0.11-0.13-0.14-0.12-0.12-0.10-0.11-0.12-0.10-0.11-0.10-0.08-0.08-0.07
EPS Actual-11.04-3.37-0.13-3.12-3.60-3.84-4.56-4.80-5.76-3.84-2.88-0.88-3.12-1.12-2.88-2.88-2.88-1.92-1.68-1.44-1.50-1.71-0.45-0.21-0.06-0.06-0.06-0.06-0.06-0.06-0.080.04-0.18-0.12-0.13-0.13-0.12-0.12-0.10-0.11-0.11-0.11-0.12-0.11-0.09-0.08-0.07-
Surprise--7.14%7.14%-7.14%0.00%-26.67%-25.00%-41.18%-14.29%20.00%-7.14%-14.29%14.29%-9.09%-33.33%-16.67%0.00%-2.04%-39.02%63.41%48.78%85.71%86.36%82.86%82.86%-50.00%----0.00%-18.18%0.00%14.29%0.00%16.67%-10.00%0.00%12.17%-20.00%0.00%5.26%0.00%12.50%-
TimingAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap112.75M
Enterprise Value108.91M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book5.85
EPS-0.36
Book Value0.212
Revenue (TTM)0
Gross Profit (TTM)130.00K
EBITDA-26.88M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-220.41%
Return on Assets-48.47%
Shares Outstanding90.20M
Shares Float38.94M
Beta3.28
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 2 analystsTarget 3.83
  • Buy
    2

Ownership Breakdown

Institutions
5.89%
Insiders
55.39%
Retail / Other
38.72%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    1.53M1.70%
  • Tanager Wealth Management LLP
    607.28K0.67%
  • Geode Capital Management, LLC
    600.58K0.67%
  • Tudor Investment Corp Et AL
    410.90K0.46%
  • UBS Group AG
    337.75K0.37%
  • Commonwealth Equity Services, LLC
    330.56K0.37%
  • BlackRock Inc
    297.50K0.33%
  • Vanguard Fiduciary Trust Co
    263.83K0.29%
  • Monetary Management Group Inc
    193.98K0.21%
  • State Street Corp
    154.97K0.17%
  • EVOKE WEALTH, LLC
    99.87K0.11%
  • Northern Trust Corp
    96.46K0.11%
  • Marshall Wace Asset Management Ltd
    92.27K0.10%
  • Susquehanna International Group, LLP
    86.29K0.10%
  • SIMPLEX TRADING, LLC
    68.20K0.08%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.11M1.23%
  • Fidelity Extended Market Index
    282.83K0.31%
  • iShares Micro-Cap ETF
    132.83K0.15%
  • Fidelity Total Market Index
    106.36K0.12%
  • Fidelity Series Total Market Index
    79.81K0.09%

Stock Splits

  • Aug 19, 20221:3
  • Jan 6, 20201:8